Evidence map›Paper›PMID 39655936›Full record

ArticlemBio2025

Characterization of

Caitlin E Gabor, Charlotte E Chong, Jose M Lemme-Dumit, Tracy H Hazen, Kate S Baker, Karen L Kotloff, Irene N Kasumba, Sharon M Tennant, Henry Badji, M Jahangir Hossain and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in mBio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Caitlin E GaborInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA.ORCID 0009-0001-7482-9060
Charlotte E ChongDepartment of Genetics, University of Cambridge, Cambridge, United Kingdom.
Jose M Lemme-DumitCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Tracy H HazenInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Kate S BakerDepartment of Genetics, University of Cambridge, Cambridge, United Kingdom.
Karen L KotloffCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Irene N KasumbaCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Sharon M TennantDepartment of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0002-0651-5748
Henry BadjiMedical Research Council Unit, The Gambia at the London School of Hygiene & Tropical Medicine, Banjul, The Gambia.
M Jahangir HossainMedical Research Council Unit, The Gambia at the London School of Hygiene & Tropical Medicine, Banjul, The Gambia.
Richard OmoreKenya Medical Research Institute, Center for Global Health Research (KEMRI-CGHR), Kisumu, Kenya.
Benjamin OchiengKenya Medical Research Institute, Center for Global Health Research (KEMRI-CGHR), Kisumu, Kenya.
Alex O AwuorKenya Medical Research Institute, Center for Global Health Research (KEMRI-CGHR), Kisumu, Kenya.
Billy OgwelKenya Medical Research Institute, Center for Global Health Research (KEMRI-CGHR), Kisumu, Kenya.
Jane JumaKenya Medical Research Institute, Center for Global Health Research (KEMRI-CGHR), Kisumu, Kenya.
Eileen M BarryCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0002-5326-0047
David A RaskoInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0002-7337-7154

Funding

Technology CoreU19AI110820 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI WHITE, OWEN R · 2014 to 2023
$36.5M
Probiotic yeast secreting single-domain antibodies to prevent Clostridium difficile and Campylobacter jejuni diseaseU19AI142725 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI LEVINE, MYRON MAX · 2019 to 2023
$12.5M
HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) U19AI110820NIAID NIH HHS U19 AI110820NIAID NIH HHS U19 AI142725
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Dysentery, BacillarySerogroupShigella flexneriVirulence FactorsAnti-Bacterial AgentsDeveloping CountriesGenome, BacterialHumansPlasmidsVirulenceAnti-Bacterial AgentsVirulence Factorscomparative genomicshost-pathogen interactionsShigellaShigella flexneriShigella flexneri serotype 6

Identifiers

PMID39655936
PMCPMC11708030

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.